Home > Income Statement > CONCORD BIOTECH

CONCORD BIOTECH
Consolidated Net Profit

    Back to Income Statement
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹308 Cr₹240 Cr₹175 Cr₹235 Cr₹169 Cr

What is the latest Consolidated Net Profit of CONCORD BIOTECH ?

The latest Consolidated Net Profit ratio of CONCORD BIOTECH is ₹308 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹308 Cr
Mar2023₹240 Cr
Mar2022₹175 Cr
Mar2021₹235 Cr
Mar2020₹169 Cr

How is Consolidated Net Profit of CONCORD BIOTECH Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹308 Cr
28.33
Mar2023 ₹240 Cr
37.25
Mar2022 ₹175 Cr
-25.51
Mar2021 ₹235 Cr
38.99
Mar2020 ₹169 Cr -

Compare Consolidated Net Profit of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹18,196.2 Cr -5.9% -5.9% 13.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,284.0 Cr -0% -0.4% 10.2% Stock Analytics
DIVIS LABORATORIES ₹183,268.0 Cr 1.4% 4.1% 50.3% Stock Analytics
CIPLA ₹122,253.0 Cr 0.5% 1.6% 1.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹113,988.0 Cr -1.2% 7.1% 18.3% Stock Analytics
DR REDDYS LABORATORIES ₹108,921.0 Cr 1.7% 1.2% 1.5% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-5.9%

-5.9%

13.6%

SENSEX

-0.7%

3%

5%


You may also like the below Video Courses